Crossmark

Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales

Crossref DOI link: https://doi.org/10.1186/s12879-024-10133-5

Published Online: 2024-11-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sader, Helio S.

Kimbrough, John H.

Mendes, Rodrigo E.

Castanheira, Mariana
Funding

Funding for this research was provided by:

AbbVie (22-ALG-04 M4, 22-ALG-04 M4, 22-ALG-04 M4, 22-ALG-04 M4)
License Information

Text and Data Mining valid from 2024-11-05

Version of Record valid from 2024-11-05
More Information

Article History

Received: 11 April 2024

Accepted: 28 October 2024

First Online: 5 November 2024

Declarations

:

: This study does not include factors necessitating patient consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below